Extracellular vesicles from human adipose derived stem cells for the improvement of angiogenesis and fat grafting application.
The efficacy of autologous fat transplantation is reduced by fat absorption and fibrosis that are closely related to unsatisfactory vascularization. Extracellular vesicles (EVs) are key components of the cell secretome, which can mirror the functional and molecular characteristics of their parental cells. Growing evidence has revealed that adipose-derived mesenchymal stem cells (ADSCs) have the ability to enhance vascularization which is partly ascribed to EVs. We evaluated whether ADSC-derived extracellular vesicles (ADSC-EVs) improved vascularization of fat grafts and increased their retention rate. To test the angiogenesis ability of ADSC-EVs, they were isolated from the supernatant of cultured human ADSCs and incubated with human umbilical vein endothelial cells (HUVECs) in vitro. Then, ADSC-EVs were co-transplanted with fat into nude mice subcutaneously. After 3 months of transplantation, retention rate and inflammatory reaction of the grafts were analyzed by histology assay. ADSC-EVs could significantly promote migration and tube formation of HUVECs at the concentration of 20 μg/mL. At 3 month after transplantation, the volume of fat grafts supplemented with ADSC-EVs (0.12±0.03 mm) was larger compared with the Blank group (0.05±0.01 mm). Histological analysis demonstrated that transplants in the EV group had significantly less cysts, vacuoles, and fibrosis. Immunohistology assay further confirmed that ADSC-EVs could also promote vascularization (CD31-positive vessels: 9.8±1.7/field vs 20.0±4.9/field, P<0.05) and regulate inflammatory response (CD206-positive cells: 16.8±5.2/field vs 26.2±5.5/field, P<0.05). In this study, we co-transplanted ADSC-EVs with fat into nude mouse model and found that ADSC-EVs improved volume retention by enhancing vascularization and regulating the inflammatory response.